Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc

FRLN
Freeline Therapeutics Holdings plcUS flagNASDAQ Global Select
6.49
USD
+0.01
- -
28.28MMarket Cap

Freeline Therapeutics Holdings plc (FRLN) Stock Splits

Learn about Freeline Therapeutics Holdings plc's most recent 1-for-15 basis stock split on May 12, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Freeline Therapeutics Holdings plc's most recent stock split

Split Date: 2023-05-12
Split Ratio: 1:15
Price Before Split: $0.21
Price After Split: $0.01

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Freeline Therapeutics Holdings plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-05-121:15Yes$0.21$0.01

About Freeline Therapeutics Holdings plc

Company overview and industry information

Freeline Therapeutics Holdings plc (FRLN) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Freeline Therapeutics Holdings plc Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.